Windlas Biotech IPO is unlocked for 3 days’ subscription i.e. from 4th August 2021 to 6th August 2021 with a price bracket of Rs.448-460 per equity share. The company got incorporated in the year 2001 and over the years became the leading company in pharmaceutical formulations.
Furthermore, the Dehradun-based company offers an array of CDMO services ranging from product finding to product expansion, licensing, and commercial manufacturing of generic products which includes complex generics.
The company is also engaged in selling its own branded products in OTC markets. At present, the company is planning to launch composite generic products which will be classified under chronic therapeutic groups further related to lifestyle syndrome.
Moreover, the company has its industrial plant in Dehradun with an installed adequate storage capacity.
Let’s have a detailed view of Windlas Biotech IPO:
Promoters of the Company
Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family PVT Trust are the promoters of the company.
Issuance of Shares
Issue size: Rs.401.54 crore
Face value: Rs.5
Listing At: BSE & NSE
The Objective of the Issuance of Shares
- Augmenting additional working capital requirements
- In order to meet general corporate purposes
- To repay or pre-pay company’s borrowings wholly or partially
- To purchase equipment requiring for capacity expansion
IPO Share Price
The company decides the price bracket at Rs.448-460 per equity share.
Retailers Reserved Lot size
Up to 14 lots i.e. 420 shares which makes a total of Rs. 193,200 are valid for subscription, in the case of the retail individual investors.
IPO Opening and Closing date
Windlas Biotech IPO unlocks for 3 days’ subscription i.e. from 4th August 2021 to 6th August 2021.
Lot size and Minimum number of shares
Each lot size includes a total of 30 shares. an investor should subscribe for a minimum count of 30 shares only.
Allotment of Shares
The allotment of shares will be done on 11th August 2021 and the shares allotted will be transferred to your Demat account by 13th August 2021.
IPO listing date
The IPO listing date of Windlas Biotech is yet to decide. Moreover, the expected date may be 17th August 2021.
Trendy Analysis
Windlas Biotech is a prominent market player in domestic pharmaceutical makings. Moreover, the company has a strong client base of leading pharmaceutical companies like Pfizer Ltd, Cadila Healthcare LTD, and many more. Looking into the financials of the company then the top line shows a gradual growth whereas the bottom line depicts a dipping trend. But still, experts forecast an abundant growth opportunity for long-term investors.
